Corcept Therapeutics
CORT
$23.92
Share price
-4.55%
Change (1 day)
6.83%
Change (1 year)
Categories
Corcept Therapeutics (CORT) - Cash on Hand
Cash on Hand as of December 2023 : $0.36 B
According to Corcept Therapeutics
's latest financial reports the company has $0.36 B in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Corcept Therapeutics - Cash on Hand chart (from 2003 to 2023)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2023-12-31 | $0.36 B | -14.7% |
| 2022-12-31 | $0.43 B | 93.11% |
| 2021-12-31 | $0.22 B | -49.28% |
| 2020-12-31 | $0.44 B | 59.69% |
| 2019-12-31 | $0.27 B | 33.47% |
| 2018-12-31 | $0.20 B | 132.98% |
| 2017-12-31 | $88.74 M | 72.2% |
| 2016-12-31 | $51.53 M | 27.45% |
| 2015-12-31 | $40.43 M | 66.76% |
| 2014-12-31 | $24.24 M | -55.81% |
| 2013-12-31 | $54.87 M | -41.01% |
| 2012-12-31 | $93.03 M | 134.72% |
| 2011-12-31 | $39.63 M | 61.26% |
| 2010-12-31 | $24.57 M | 2.98% |
| 2009-12-31 | $23.86 M | 30.36% |
| 2008-12-31 | $18.3 M | 5.43% |
| 2007-12-31 | $17.36 M | 83.65% |
| 2006-12-31 | $9.45 M | -67.48% |
| 2005-12-31 | $29.08 M | -22.25% |
| 2004-12-31 | $37.4 M | 223.06% |
| 2003-12-31 | $11.57 M |
Cash on Hand for similar companies or competitors
| Company | Cash on Hand | differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $22.92 B | 6,126.42% | 🇺🇸 USA |
 Novartis NVS | $9.69 B | 2,532.66% | 🇨🇭 Switzerland |
 Pfizer PFE | $12.69 B | 3,346.30% | 🇺🇸 USA |
 Eli Lilly LLY | $2.92 B | 695.09% | 🇺🇸 USA |
 Merck MRK | $7.09 B | 1,826.29% | 🇺🇸 USA |
 Bristol-Myers Squibb BMY | $9.67 B | 2,526.14% | 🇺🇸 USA |
 MannKind Corp MNKD | $0.29 B | -19.86% | 🇺🇸 USA |
 Esperion Therapeutics ESPR | $82.24 M | -77.66% | 🇺🇸 USA |
 BioMarin Pharmaceutical BMRN | $1.07 B | 191.62% | 🇺🇸 USA |